LaserAway is exploring a sale that could value the medical spa chain at more than $2B. The Los Angeles-based provider generates approximately $150M in annual EBITDA across 219 locations. This potential transaction highlights the growing private equity appetite for medical aesthetics businesses that offer high recurring revenue through repeat treatments.
LaserAway explores sale at valuation over 2 billion dollars
The Los Angeles-based medical spa chain LaserAway is working with investment bank Harris Williams to explore a potential sale. Backed by Ares Management and Seidler Equity Partners, the company generates approximately 150 million dollars in annual EBITDA and operates over 200 locations.
Insights:









